| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Crohn Disease | 25 | 2016 | 351 | 1.970 |
Why?
|
| Colitis, Ulcerative | 15 | 2014 | 268 | 1.700 |
Why?
|
| Inflammatory Bowel Diseases | 13 | 2012 | 363 | 0.950 |
Why?
|
| Foundations | 2 | 2010 | 26 | 0.540 |
Why?
|
| Gastroenterology | 2 | 2010 | 195 | 0.520 |
Why?
|
| Aminosalicylic Acids | 3 | 1998 | 5 | 0.400 |
Why?
|
| Pediatrics | 4 | 2010 | 1141 | 0.380 |
Why?
|
| Child | 42 | 2016 | 29154 | 0.260 |
Why?
|
| Awards and Prizes | 1 | 2006 | 98 | 0.250 |
Why?
|
| Child Nutritional Physiological Phenomena | 2 | 2008 | 174 | 0.240 |
Why?
|
| Child, Preschool | 26 | 2016 | 16273 | 0.220 |
Why?
|
| Biomedical Research | 1 | 2010 | 806 | 0.210 |
Why?
|
| Infant | 21 | 2016 | 13310 | 0.210 |
Why?
|
| Gastrointestinal Agents | 4 | 2006 | 108 | 0.210 |
Why?
|
| Adolescent | 35 | 2016 | 31252 | 0.200 |
Why?
|
| Immunologic Factors | 3 | 2011 | 649 | 0.200 |
Why?
|
| Diverticulum, Esophageal | 1 | 2000 | 5 | 0.190 |
Why?
|
| Anti-Inflammatory Agents | 5 | 2011 | 461 | 0.190 |
Why?
|
| Self Care | 1 | 2002 | 224 | 0.190 |
Why?
|
| Antibodies, Monoclonal | 6 | 2011 | 4367 | 0.160 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 1998 | 39 | 0.160 |
Why?
|
| Sulfasalazine | 2 | 1998 | 16 | 0.160 |
Why?
|
| Proctocolectomy, Restorative | 2 | 2012 | 20 | 0.150 |
Why?
|
| Gastroesophageal Reflux | 3 | 2007 | 334 | 0.150 |
Why?
|
| Intestinal Mucosa | 2 | 2014 | 1081 | 0.140 |
Why?
|
| Bacterial Typing Techniques | 1 | 2016 | 139 | 0.130 |
Why?
|
| Mesalamine | 2 | 2011 | 9 | 0.130 |
Why?
|
| Gastrointestinal Diseases | 2 | 1999 | 589 | 0.130 |
Why?
|
| Humans | 64 | 2016 | 261506 | 0.130 |
Why?
|
| Dysbiosis | 1 | 2016 | 134 | 0.130 |
Why?
|
| Growth Disorders | 2 | 2008 | 218 | 0.120 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 1994 | 340 | 0.120 |
Why?
|
| Duodenal Ulcer | 1 | 1994 | 113 | 0.120 |
Why?
|
| DNA Methylation | 2 | 2014 | 2669 | 0.110 |
Why?
|
| Hypoalbuminemia | 1 | 2012 | 46 | 0.110 |
Why?
|
| Serum Albumin | 2 | 2012 | 257 | 0.110 |
Why?
|
| Female | 44 | 2014 | 141928 | 0.110 |
Why?
|
| Incidence | 6 | 2012 | 5673 | 0.110 |
Why?
|
| Nutrition Disorders | 2 | 2002 | 57 | 0.110 |
Why?
|
| Opportunistic Infections | 1 | 1994 | 223 | 0.110 |
Why?
|
| Quality of Life | 4 | 2008 | 4532 | 0.110 |
Why?
|
| Aspergillosis | 1 | 1994 | 246 | 0.100 |
Why?
|
| Texas | 4 | 2011 | 6311 | 0.100 |
Why?
|
| Male | 36 | 2014 | 123000 | 0.100 |
Why?
|
| Cholesterol Ester Storage Disease | 1 | 1991 | 3 | 0.100 |
Why?
|
| Immunosuppressive Agents | 2 | 2012 | 1375 | 0.100 |
Why?
|
| Infliximab | 5 | 2011 | 130 | 0.100 |
Why?
|
| Failure to Thrive | 1 | 2011 | 91 | 0.100 |
Why?
|
| Infant, Newborn | 9 | 2010 | 8223 | 0.090 |
Why?
|
| Colon | 1 | 2014 | 670 | 0.090 |
Why?
|
| Age Factors | 5 | 2011 | 5377 | 0.090 |
Why?
|
| Microbiota | 1 | 2016 | 547 | 0.090 |
Why?
|
| Immunocompromised Host | 1 | 1994 | 698 | 0.090 |
Why?
|
| Stomatitis, Aphthous | 1 | 2009 | 7 | 0.090 |
Why?
|
| Steroids | 1 | 2011 | 356 | 0.090 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2012 | 709 | 0.080 |
Why?
|
| Liver Transplantation | 3 | 1995 | 1112 | 0.080 |
Why?
|
| Bone Marrow Transplantation | 1 | 1994 | 1581 | 0.080 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2010 | 408 | 0.080 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 980 | 0.080 |
Why?
|
| Folic Acid Deficiency | 1 | 2008 | 54 | 0.080 |
Why?
|
| Aortitis | 1 | 2008 | 8 | 0.080 |
Why?
|
| Anal Canal | 1 | 2009 | 238 | 0.080 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2009 | 375 | 0.080 |
Why?
|
| Weight Loss | 1 | 2012 | 627 | 0.080 |
Why?
|
| Medicaid | 1 | 2011 | 279 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 1323 | 0.080 |
Why?
|
| Severity of Illness Index | 8 | 2011 | 4320 | 0.080 |
Why?
|
| Arthritis | 1 | 2009 | 139 | 0.080 |
Why?
|
| Digestive System Surgical Procedures | 2 | 2010 | 275 | 0.080 |
Why?
|
| Growth Hormone | 1 | 2008 | 226 | 0.080 |
Why?
|
| North America | 3 | 2007 | 314 | 0.080 |
Why?
|
| Chemokine CCL2 | 1 | 2008 | 203 | 0.080 |
Why?
|
| Transcription Factor AP-1 | 1 | 2008 | 246 | 0.080 |
Why?
|
| Complementary Therapies | 1 | 2009 | 126 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 521 | 0.070 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2008 | 301 | 0.070 |
Why?
|
| Cholesterol Esters | 4 | 1995 | 34 | 0.070 |
Why?
|
| United States | 6 | 2011 | 15433 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2009 | 1538 | 0.070 |
Why?
|
| Folic Acid | 1 | 2008 | 349 | 0.070 |
Why?
|
| Tacrolimus | 2 | 2012 | 335 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 2508 | 0.070 |
Why?
|
| Lactobacillus | 1 | 2005 | 58 | 0.070 |
Why?
|
| Cholestasis, Extrahepatic | 1 | 1985 | 13 | 0.070 |
Why?
|
| Histamine H1 Antagonists | 1 | 2005 | 25 | 0.070 |
Why?
|
| Nutritional Support | 1 | 2006 | 80 | 0.070 |
Why?
|
| Bone Density | 2 | 2008 | 476 | 0.070 |
Why?
|
| Research | 2 | 2006 | 415 | 0.060 |
Why?
|
| Premedication | 1 | 2005 | 135 | 0.060 |
Why?
|
| Bile Ducts | 1 | 1985 | 113 | 0.060 |
Why?
|
| Cholestasis, Intrahepatic | 1 | 1985 | 74 | 0.060 |
Why?
|
| Case-Control Studies | 4 | 2016 | 6100 | 0.060 |
Why?
|
| Sex Factors | 1 | 2010 | 2139 | 0.060 |
Why?
|
| Psychology | 1 | 2004 | 86 | 0.060 |
Why?
|
| Drug Hypersensitivity | 1 | 2005 | 128 | 0.060 |
Why?
|
| Growth | 1 | 2004 | 117 | 0.060 |
Why?
|
| History, 21st Century | 1 | 2006 | 441 | 0.060 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2005 | 126 | 0.060 |
Why?
|
| Body Mass Index | 1 | 2011 | 2203 | 0.060 |
Why?
|
| History, 20th Century | 1 | 2006 | 574 | 0.060 |
Why?
|
| Cyclosporine | 2 | 2012 | 278 | 0.050 |
Why?
|
| Probiotics | 1 | 2005 | 228 | 0.050 |
Why?
|
| Surveys and Questionnaires | 5 | 2009 | 5687 | 0.050 |
Why?
|
| Anti-Ulcer Agents | 1 | 2002 | 101 | 0.050 |
Why?
|
| Omeprazole | 1 | 2002 | 92 | 0.050 |
Why?
|
| Age of Onset | 3 | 2009 | 827 | 0.050 |
Why?
|
| Glucocorticoids | 1 | 2005 | 629 | 0.050 |
Why?
|
| Remission Induction | 4 | 2011 | 3569 | 0.050 |
Why?
|
| Genetic Variation | 1 | 2009 | 2086 | 0.050 |
Why?
|
| Cohort Studies | 6 | 2010 | 9244 | 0.050 |
Why?
|
| Stress, Psychological | 1 | 2008 | 1000 | 0.050 |
Why?
|
| Esophagitis | 1 | 2002 | 202 | 0.050 |
Why?
|
| Manometry | 1 | 2000 | 74 | 0.050 |
Why?
|
| Enteral Nutrition | 1 | 1983 | 316 | 0.050 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2007 | 1209 | 0.040 |
Why?
|
| Retrospective Studies | 7 | 2010 | 37905 | 0.040 |
Why?
|
| Body Height | 3 | 2008 | 231 | 0.040 |
Why?
|
| Jaundice, Neonatal | 1 | 1998 | 12 | 0.040 |
Why?
|
| Erythroblastosis, Fetal | 1 | 1998 | 18 | 0.040 |
Why?
|
| Cholagogues and Choleretics | 1 | 1998 | 33 | 0.040 |
Why?
|
| Ursodeoxycholic Acid | 1 | 1998 | 51 | 0.040 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2007 | 1303 | 0.040 |
Why?
|
| Recurrence | 3 | 2005 | 4758 | 0.040 |
Why?
|
| Pulmonary Artery | 3 | 1998 | 499 | 0.040 |
Why?
|
| Ileitis | 1 | 1998 | 12 | 0.040 |
Why?
|
| Time Factors | 7 | 2012 | 12926 | 0.040 |
Why?
|
| Digestive System | 1 | 1998 | 114 | 0.040 |
Why?
|
| Health Maintenance Organizations | 1 | 1997 | 29 | 0.040 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 1998 | 44 | 0.040 |
Why?
|
| Hypertension, Portal | 2 | 1991 | 124 | 0.040 |
Why?
|
| Lipid Metabolism, Inborn Errors | 3 | 1986 | 22 | 0.040 |
Why?
|
| Algorithms | 2 | 2011 | 3890 | 0.040 |
Why?
|
| Alagille Syndrome | 1 | 1998 | 44 | 0.040 |
Why?
|
| Molecular Epidemiology | 1 | 1997 | 246 | 0.040 |
Why?
|
| Follow-Up Studies | 5 | 2011 | 14889 | 0.040 |
Why?
|
| Clinical Trials as Topic | 2 | 2005 | 3719 | 0.040 |
Why?
|
| Drug Therapy, Combination | 3 | 2009 | 2315 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2012 | 5539 | 0.030 |
Why?
|
| Adult | 12 | 2012 | 77950 | 0.030 |
Why?
|
| Cytoplasm | 1 | 1998 | 652 | 0.030 |
Why?
|
| Radiography | 1 | 2000 | 1904 | 0.030 |
Why?
|
| Treatment Outcome | 8 | 2011 | 32848 | 0.030 |
Why?
|
| Health Status | 1 | 1999 | 590 | 0.030 |
Why?
|
| Recombinant Proteins | 3 | 2010 | 2927 | 0.030 |
Why?
|
| Catheterization | 1 | 1998 | 410 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2000 | 4744 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2010 | 544 | 0.030 |
Why?
|
| Lactose Intolerance | 2 | 1971 | 11 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2010 | 5542 | 0.030 |
Why?
|
| Lysosomal Storage Diseases | 1 | 1995 | 35 | 0.030 |
Why?
|
| Registries | 3 | 2008 | 2170 | 0.030 |
Why?
|
| Prevalence | 1 | 2002 | 3260 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2005 | 2588 | 0.030 |
Why?
|
| Immunity, Mucosal | 1 | 2014 | 108 | 0.030 |
Why?
|
| Milk | 2 | 1971 | 120 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2009 | 1819 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 1998 | 1620 | 0.030 |
Why?
|
| Genome-Wide Association Study | 2 | 2012 | 2265 | 0.030 |
Why?
|
| Calcineurin Inhibitors | 1 | 2012 | 68 | 0.030 |
Why?
|
| Feces | 1 | 2016 | 770 | 0.030 |
Why?
|
| Diseases in Twins | 1 | 2012 | 99 | 0.030 |
Why?
|
| Twins, Monozygotic | 1 | 2012 | 129 | 0.030 |
Why?
|
| Stents | 1 | 1998 | 1096 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 1992 | 224 | 0.020 |
Why?
|
| Mexico | 1 | 1991 | 259 | 0.020 |
Why?
|
| Intestinal Fistula | 1 | 2010 | 44 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1998 | 4938 | 0.020 |
Why?
|
| Spiritual Therapies | 1 | 2009 | 6 | 0.020 |
Why?
|
| Liver | 3 | 1991 | 2961 | 0.020 |
Why?
|
| Plant Preparations | 1 | 2009 | 36 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 2010 | 310 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2010 | 875 | 0.020 |
Why?
|
| Family | 1 | 2012 | 736 | 0.020 |
Why?
|
| Endocrine System | 1 | 2008 | 36 | 0.020 |
Why?
|
| Kidney Failure, Chronic | 2 | 1995 | 960 | 0.020 |
Why?
|
| Nutrition Policy | 1 | 2008 | 111 | 0.020 |
Why?
|
| Smoking | 1 | 1997 | 2440 | 0.020 |
Why?
|
| Genetic Markers | 1 | 1991 | 974 | 0.020 |
Why?
|
| Patient Selection | 2 | 2011 | 2055 | 0.020 |
Why?
|
| Constipation | 1 | 2009 | 177 | 0.020 |
Why?
|
| Intestinal Obstruction | 1 | 2010 | 202 | 0.020 |
Why?
|
| Social Adjustment | 1 | 2008 | 114 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2008 | 356 | 0.020 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2008 | 216 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2014 | 1399 | 0.020 |
Why?
|
| Body Image | 1 | 2008 | 141 | 0.020 |
Why?
|
| Nutritional Status | 1 | 2008 | 337 | 0.020 |
Why?
|
| Liver Cirrhosis | 2 | 1991 | 941 | 0.020 |
Why?
|
| Splanchnic Circulation | 1 | 1986 | 53 | 0.020 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1986 | 140 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2009 | 1471 | 0.020 |
Why?
|
| Hemangioma, Cavernous | 1 | 1986 | 27 | 0.020 |
Why?
|
| Gene Expression | 1 | 2014 | 3570 | 0.020 |
Why?
|
| Arteriovenous Malformations | 1 | 1986 | 70 | 0.020 |
Why?
|
| Anemia | 2 | 2008 | 689 | 0.020 |
Why?
|
| Liver Diseases | 1 | 1991 | 574 | 0.020 |
Why?
|
| Technetium | 1 | 1985 | 77 | 0.020 |
Why?
|
| Splenic Neoplasms | 1 | 1986 | 119 | 0.020 |
Why?
|
| Middle Aged | 4 | 2012 | 86204 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2006 | 460 | 0.020 |
Why?
|
| Infusions, Parenteral | 1 | 2005 | 191 | 0.020 |
Why?
|
| Body Composition | 1 | 2008 | 595 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 1489 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2008 | 1382 | 0.020 |
Why?
|
| Europe | 1 | 2006 | 649 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2007 | 417 | 0.020 |
Why?
|
| Endpoint Determination | 1 | 2005 | 176 | 0.020 |
Why?
|
| Intestinal Diseases | 1 | 2006 | 121 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 1971 | 808 | 0.020 |
Why?
|
| Jejunum | 1 | 1986 | 216 | 0.020 |
Why?
|
| Granuloma | 1 | 2006 | 154 | 0.020 |
Why?
|
| Data Collection | 1 | 2007 | 620 | 0.020 |
Why?
|
| Placebos | 1 | 2005 | 437 | 0.020 |
Why?
|
| Infant, Low Birth Weight | 1 | 1985 | 181 | 0.020 |
Why?
|
| Hemangioma | 1 | 1986 | 154 | 0.020 |
Why?
|
| Young Adult | 2 | 2014 | 21445 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2009 | 558 | 0.020 |
Why?
|
| Cholestasis | 1 | 1986 | 203 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1985 | 660 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2008 | 4314 | 0.010 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 1986 | 238 | 0.010 |
Why?
|
| Demography | 1 | 2005 | 435 | 0.010 |
Why?
|
| Lipase | 3 | 1995 | 112 | 0.010 |
Why?
|
| Risk Factors | 3 | 2008 | 17523 | 0.010 |
Why?
|
| Antibodies | 1 | 2006 | 838 | 0.010 |
Why?
|
| Hypertension, Pulmonary | 2 | 1986 | 462 | 0.010 |
Why?
|
| Intestine, Small | 1 | 1986 | 499 | 0.010 |
Why?
|
| Lansoprazole | 1 | 2002 | 19 | 0.010 |
Why?
|
| 2-Pyridinylmethylsulfinylbenzimidazoles | 1 | 2002 | 25 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 3639 | 0.010 |
Why?
|
| Intestines | 1 | 1986 | 686 | 0.010 |
Why?
|
| Genome, Human | 1 | 2009 | 1869 | 0.010 |
Why?
|
| Azathioprine | 1 | 2000 | 66 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2002 | 585 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2006 | 3472 | 0.010 |
Why?
|
| Mercaptopurine | 1 | 2000 | 130 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2009 | 12873 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2012 | 6869 | 0.010 |
Why?
|
| Proton Pump Inhibitors | 1 | 2002 | 249 | 0.010 |
Why?
|
| Feasibility Studies | 2 | 1997 | 2292 | 0.010 |
Why?
|
| Arterial Occlusive Diseases | 1 | 1979 | 160 | 0.010 |
Why?
|
| Research Design | 1 | 2005 | 1544 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2006 | 4988 | 0.010 |
Why?
|
| Disease Progression | 1 | 2008 | 6682 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2008 | 4053 | 0.010 |
Why?
|
| Survival Rate | 1 | 2010 | 12221 | 0.010 |
Why?
|
| Angiography | 1 | 1998 | 360 | 0.010 |
Why?
|
| Urban Population | 1 | 1997 | 269 | 0.010 |
Why?
|
| Radiography, Thoracic | 1 | 1998 | 462 | 0.010 |
Why?
|
| Prosthesis Design | 1 | 1998 | 749 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 1997 | 11538 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 1997 | 538 | 0.010 |
Why?
|
| Phenotype | 1 | 2005 | 6295 | 0.010 |
Why?
|
| Biomarkers | 1 | 2005 | 5047 | 0.010 |
Why?
|
| Cholesterol | 1 | 1977 | 658 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 1995 | 347 | 0.010 |
Why?
|
| Cardiac Catheterization | 1 | 1998 | 687 | 0.010 |
Why?
|
| Blood Sedimentation | 1 | 1992 | 35 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2008 | 7551 | 0.010 |
Why?
|
| Hematocrit | 1 | 1992 | 142 | 0.010 |
Why?
|
| Abnormalities, Multiple | 1 | 1998 | 998 | 0.010 |
Why?
|
| Kanamycin Kinase | 1 | 1991 | 18 | 0.010 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 1998 | 705 | 0.010 |
Why?
|
| Phosphotransferases | 1 | 1991 | 84 | 0.010 |
Why?
|
| Retroviridae | 1 | 1991 | 332 | 0.010 |
Why?
|
| Genetics, Medical | 1 | 1971 | 143 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 1991 | 475 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 1986 | 4557 | 0.010 |
Why?
|
| Dogs | 1 | 1991 | 1155 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 1991 | 467 | 0.010 |
Why?
|
| Pain Measurement | 1 | 1992 | 953 | 0.000 |
Why?
|
| Lung | 1 | 1979 | 3151 | 0.000 |
Why?
|
| Informed Consent | 1 | 1991 | 419 | 0.000 |
Why?
|
| Body Weight | 1 | 1992 | 1293 | 0.000 |
Why?
|
| Graft Survival | 1 | 1991 | 1062 | 0.000 |
Why?
|
| Arteriosclerosis | 1 | 1986 | 185 | 0.000 |
Why?
|
| Kidney | 1 | 1995 | 2146 | 0.000 |
Why?
|
| Acute Disease | 1 | 1991 | 2422 | 0.000 |
Why?
|
| Genetic Vectors | 1 | 1991 | 1694 | 0.000 |
Why?
|
| Hypertension | 1 | 1995 | 1503 | 0.000 |
Why?
|
| Cerebral Hemorrhage | 1 | 1986 | 183 | 0.000 |
Why?
|
| Polymerase Chain Reaction | 1 | 1991 | 3203 | 0.000 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 1986 | 137 | 0.000 |
Why?
|
| Birth Weight | 1 | 1986 | 374 | 0.000 |
Why?
|
| Infant, Newborn, Diseases | 1 | 1986 | 186 | 0.000 |
Why?
|
| Intestinal Neoplasms | 1 | 1986 | 189 | 0.000 |
Why?
|
| Aging | 1 | 1971 | 1582 | 0.000 |
Why?
|
| Immunoglobulin G | 1 | 1986 | 1021 | 0.000 |
Why?
|
| Risk | 1 | 1986 | 1972 | 0.000 |
Why?
|
| Longitudinal Studies | 1 | 1986 | 1945 | 0.000 |
Why?
|
| Lymphocyte Activation | 1 | 1986 | 1688 | 0.000 |
Why?
|
| Sepsis | 1 | 1986 | 652 | 0.000 |
Why?
|
| Pneumonia | 1 | 1986 | 751 | 0.000 |
Why?
|
| B-Lymphocytes | 1 | 1986 | 1294 | 0.000 |
Why?
|
| Animals | 3 | 1991 | 59536 | 0.000 |
Why?
|
| Hepatomegaly | 1 | 1977 | 69 | 0.000 |
Why?
|
| Histocytochemistry | 1 | 1977 | 185 | 0.000 |
Why?
|
| Splenomegaly | 1 | 1977 | 158 | 0.000 |
Why?
|
| Triglycerides | 1 | 1977 | 603 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 1986 | 3869 | 0.000 |
Why?
|
| Aged | 1 | 1997 | 70117 | 0.000 |
Why?
|
| Fibroblasts | 1 | 1977 | 1682 | 0.000 |
Why?
|
| Mice | 1 | 1991 | 34495 | 0.000 |
Why?
|
| Socioeconomic Factors | 1 | 1971 | 1225 | 0.000 |
Why?
|